Company: AZN
Filing Date: 2025-09-29
Form Type: 6-K
Source: 0001104659-25-094039
Chunk: 20

Company: ASTRAZENECA PLC
Filing Date: 2025-09-29
Form: 6-K
Chunk 20
---
 dividends and participate in capital events, so far as practicable, in the same manner as registered holders of AstraZeneca Shares.

Holders of AstraZeneca DIs will be able (with settlement occurring through AstraZeneca DIs) to trade AstraZeneca Shares on the London Stock Exchange or choose to cancel their AstraZeneca DIs (as described below) and trade the underlying AstraZeneca Shares which such AstraZeneca DIs represent on the NYSE. Following the Effective Time, holders of AstraZeneca Shares through an appointed CREST custodian or nominee should contact their chosen custodian or nominee in the event that they wish to cancel AstraZeneca DIs that they receive upon the implementation of the Harmonised Listing Structure.

Repositioning from CREST to DTC or Euroclear Sweden and related withdrawal of AstraZeneca Shares underlying AstraZeneca DIs

Following the Effective Time, holders of AstraZeneca DIs will be able to cancel their AstraZeneca DIs by submitting a cross-border instruction in respect of the underlying AstraZeneca Shares through CREST to the DI Depositary in the form of a CREST stock withdrawal message. This message must include the account information of the nominated DTC participant in accordance with the rules and practices of the DI Depositary, CREST and DTC. Shareholders intending to transact through Euroclear Sweden will be able to deliver the relevant book entry interests in AstraZeneca Shares through DTC to Euroclear Bank SA/NV, as custodian for Euroclear Sweden. When submitting such cross-border instruction, holders of AstraZeneca DIs will be required to warrant that such transfer will not represent a change in beneficial ownership.

Valid instructions received by the DI Depositary are typically completed within 48 hours (excluding any non-working days in any relevant jurisdictions) and holders of AstraZeneca DIs should consider these timings, and those of their chosen broker, when instructing corresponding trades on NYSE or Nasdaq Stockholm.

Cancellation of AstraZeneca DIs is subject to a charge. For details of the current cancellation charges or for assistance in cancelling AstraZeneca DIs and lodging cross-border instructions, holders of AstraZeneca DIs should contact the DI Depositary by phone on 0370 707 1682 (from inside the UK) or +44 (0) 370 707 1682 (from outside the UK) between 8:30 a.m